Brief: PepGen Announces IND-Enabling Preclinical Data Supporting Progression Of PGN-EDODM1 Into Clinical Studies

PepGen

07/12/2022 13:47

Dec 7 (Reuters) - PepGen Inc  PEPG.O :
    * PEPGEN ANNOUNCES IND-ENABLING PRECLINICAL DATA SUPPORTING
PROGRESSION OF PGN-EDODM1 INTO CLINICAL STUDIES
    * PEPGEN INC - ANTICIPATES INITIATING A SINGLE ASCENDING
DOSE
CLINICAL TRIAL IN DM1 PATIENTS IN FIRST HALF OF 2023
    * PEPGEN INC - PGN-EDODM1 WAS WELL-TOLERATED IN ACUTE GLP
STUDIES
IN RODENTS AND NON-HUMAN PRIMATES (NHPS) AT CLINICALLY RELEVANT
DOSES

Source text for Eikon:  ID:nGNXc98dY2 
Further company coverage:  PEPG.O